According to the Zhixingtong Finance APP, Aotec Biology (688606.SH) disclosed its third-quarter report for 2024. The company achieved revenue of 0.618 billion yuan in the first three quarters, a year-on-year growth of 10.37%; the net income attributable to the parent company was 0.198 billion yuan, a year-on-year growth of 94.48%; the non-net profit was 0.154 billion yuan, a year-on-year growth of 59.78%; and the basic earnings per share were 2.49 yuan.